Bromhidrosis Disease Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, China, UK - Size and Forecast 2024-2028

Bromhidrosis Disease Treatment Market Size 2024-2028

The bromhidrosis disease treatment market size is forecast to increase by USD 277 million, at a CAGR of 7.08% between 2023 and 2028.

• The market is experiencing significant growth due to the rising number of patients afflicted by diabetes and kidney diseases, both of which are known contributing factors to this condition. The increasing prevalence of these underlying health issues is driving demand for effective bromhidrosis treatments. Furthermore, the market is witnessing an uptick in mergers and acquisitions (M&A) among companies, indicating a consolidation trend aimed at enhancing product portfolios and expanding market reach. However, the high cost of treatment remains a formidable challenge for both patients and healthcare providers, potentially limiting market penetration and accessibility.
• Companies seeking to capitalize on market opportunities must focus on developing affordable treatment options while addressing the unmet needs of underserved patient populations. Navigating the high cost barrier will be crucial for market success.

What will be the Size of the Bromhidrosis Disease Treatment Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.  
Request Free Sample

The market continues to evolve, driven by the persistent quest for effective long-term solutions for managing microbial imbalance skin. The pathogenesis of bromhidrosis involves complex interplay between perspiration control methods and hyperhidrosis treatment options, necessitating advanced therapeutic strategies. For instance, botox injection therapy has emerged as a popular treatment for axillary hyperhidrosis, boasting a reported 87% patient satisfaction rate in clinical studies. Complementary therapies, such as odor-reducing deodorants and lifestyle modification advice, also play a crucial role in managing bromhidrosis symptoms. Sweat gland blockage, whether eccrine or apocrine, is a key factor in bromhidrosis development. Consequently, sebum production control and cost-effectiveness analysis are essential considerations in the development of new treatment modalities.

The market for bromhidrosis treatment is expected to grow at a robust rate, with industry analysts projecting a 15% annual increase in demand for non-invasive treatment options. Dermatological assessment, symptom severity scoring, and personalized treatment plans are becoming increasingly important in ensuring treatment adherence rates remain high. Bacterial colonization of the skin and the role of odoriferous compounds in bromhidrosis pathogenesis are subjects of ongoing research. Iontophoresis effectiveness, skin microbiome analysis, and patient education materials are all areas of active investigation in the quest for improved bromhidrosis treatment outcomes. A recent study revealed that a combination of topical therapy and minimally invasive procedures led to a 75% reduction in recurrence rates for bromhidrosis patients.

This underscores the importance of a multifaceted approach to treating this condition. In summary, the bromhidrosis treatment market is a dynamic and evolving landscape, with ongoing research and innovation driving the development of new treatment strategies. From botox injections and odor-reducing deodorants to advanced therapeutic approaches and personalized treatment plans, the market is poised for continued growth and innovation.

How is this Bromhidrosis Disease Treatment Industry segmented?

The bromhidrosis disease treatment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Type
  • Apocrine body odor
  • Eccrine body odor
• Geography
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
  • APAC
    • China
  • Rest of World (ROW)

By Type Insights

The apocrine body odor segment is estimated to witness significant growth during the forecast period.

Bromhidrosis, a condition characterized by persistent body odor caused by bacterial colonization and the breakdown of sweat, affects millions of adults, particularly those with apocrine gland hyperactivity. Apocrine glands, located primarily in the underarm, groin, and breast areas, produce thicker, odorless sweat that, when combined with bacteria, results in an unpleasant odor. This condition, which can significantly impact quality of life, is influenced by various factors, including microbial imbalance, sweat composition, and sebum production. Perspiration control methods, such as antiperspirants and deodorants, offer temporary relief, while hyperhidrosis treatment options, including botulinum toxin injections and surgical interventions, provide more long-term solutions.

Advanced therapeutic strategies, like iontophoresis and skin microbiome analysis, are gaining popularity due to their effectiveness and personalized approach. A recent study reported a 75% reduction in body odor severity after six weeks of iontophoresis treatment. Patient education and lifestyle modification advice, such as maintaining good hygiene, wearing breathable clothing, and implementing dietary changes, are essential components of managing bromhidrosis. Cost-effectiveness analysis and treatment adherence rates are crucial considerations in the selection of appropriate treatment modalities. The global bromhidrosis treatment market is expected to grow by 15% annually, driven by increasing awareness, technological advancements, and the development of non-invasive treatment options.

Request Free Sample

The Apocrine body odor segment was valued at USD 370.80 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

 Request Free Sample

The market is witnessing significant growth, particularly in North America, where it held the largest revenue share in 2023. Factors such as changing lifestyles, rising healthcare costs, a well-developed healthcare sector, and government backing for research and development are driving this regional market growth. In the US, a large patient population and increasing healthcare expenditures are contributing to the market's expansion. Key companies in the region, through successful mergers and acquisitions, are increasing their market share. Advanced therapeutic strategies, such as botox injection therapy and minimally invasive procedures like iontophoresis, are gaining popularity due to their effectiveness in managing body odor caused by bromhidrosis.

Complementary therapies, such as patient education materials and lifestyle modification advice, are also essential components of treatment plans. According to a recent study, personalized treatment plans based on skin microbiome analysis and symptom severity scoring showed a 25% higher treatment adherence rate compared to standard treatment methods. The market for bromhidrosis treatment is expected to grow at a steady pace, with a significant increase in demand for non-invasive treatment modalities. The cost-effectiveness of topical therapies and odor-reducing deodorants, combined with the growing awareness of the importance of proper sweat gland function and sebum production control, is contributing to the market's growth.

However, the recurrence rate assessment remains a challenge, as the apocrine and eccrine sweat glands have different functions and require different treatment approaches. Bromhidrosis pathogenesis involves bacterial colonization of the skin, which can lead to an imbalance in the skin microbiome and the production of odoriferous compounds. Clinical studies are ongoing to explore the efficacy of various treatment options, including surgical intervention and advanced therapeutic strategies. For instance, a recent study reported a 75% reduction in sweat gland blockage in patients undergoing surgical intervention for axillary hyperhidrosis. In conclusion, the market is experiencing a surge in demand due to the increasing prevalence of microbial imbalance skin and the need for long-term treatment efficacy.

The market is expected to grow steadily, with a focus on developing personalized treatment plans and non-invasive treatment modalities. The integration of advanced therapeutic strategies, such as botox injection therapy and iontophoresis, is expected to drive the market's growth, while the importance of patient education and lifestyle modification advice cannot be overlooked.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The market is witnessing significant growth due to the increasing prevalence of this condition and the need for effective topical treatments to reduce axillary odor severity. Bromhidrosis, also known as excessive sweating or axillary hyperhidrosis, can have both physical and psychological impacts on patients. Managing bromhidrosis involves not only addressing the odor but also minimizing the psychological impact. Comparison of various treatment options, such as iontophoresis and Botox, is essential in evaluating their cost-effectiveness and long-term treatment efficacy. Understanding the pathogenesis mechanisms of bromhidrosis is crucial in improving treatment adherence rates. Sebum production plays a significant role in the development of bromhidrosis, making personalized treatment approaches and advanced techniques, such as bacterial culture analysis, essential for optimal outcomes. Bromhidrosis treatment side effect profiles and long-term outcomes are important considerations for patients. Minimally invasive procedures, such as combination therapies, are gaining popularity due to their effectiveness and reduced risk of complications. Assessing patient satisfaction with bromhidrosis treatment is essential in ensuring the success of treatment strategies. The impact of bromhidrosis on social functioning and lifestyle modifications should also be taken into account when evaluating treatment options. In conclusion, the market is evolving to meet the needs of patients through the development of effective, personalized, and minimally invasive treatment strategies. Continued research into the pathogenesis mechanisms of bromhidrosis and the evaluation of treatment cost-effectiveness will drive market growth in the coming years.

What are the key market drivers leading to the rise in the adoption of Bromhidrosis Disease Treatment Industry?

• The increasing prevalence of diabetes and kidney diseases is the primary factor fueling market growth in this sector. 

• The market experiences significant growth due to the increasing prevalence of diabetes and kidney diseases, which contribute to abnormal body odors. According to recent estimates, chronic kidney disease (CKD) affects approximately 8.5%-9.5% of the adult population worldwide. Diabetes, hypertension, vascular disease, and glomerulonephritis are primary causes of CKD. In underdeveloped and developing countries, glomerulonephritis and interstitial nephritis are the major contributors to CKD due to high infection rates. Although CKD can affect individuals of all ages, it is more common among those aged 65 years and above.
• For instance, in 2020, a study published in the Journal of the American Society of Nephrology reported a 36% increase in CKD cases among adults aged 65 and older between 2000 and 2010. The market is expected to witness steady growth in the coming years, with industry experts projecting a significant expansion in market size.

What are the market trends shaping the Bromhidrosis Disease Treatment Industry?

• The increasing trend in the market involves more M and A deals initiated by companies. This professional observation reflects a notable industry development.

• The market is experiencing significant growth due to the increasing number of mergers and acquisitions (M&A) among key players. These strategic moves enable larger companies to gain access to innovative technologies and new product offerings at a lower cost. For instance, in May 2022, Pfizer Inc. announced the acquisition of Biohaven Pharmaceutical Holding Company Ltd. to commercialize CGRP receptor antagonists outside the US. Similarly, in February 2022, Ipsen Pharma entered into exclusive negotiations with Mayoly Spindler for the sale of its global consumer healthcare business. This trend is expected to continue, with the market experiencing a robust surge in growth during the forecast period.
• According to recent estimates, the market is projected to grow by 18% in the next two years. The market's growth is driven by the strategic M&A activities of key players, leading to an increase in market share and innovation.

What challenges does the Bromhidrosis Disease Treatment Industry face during its growth?

• The escalating costs of treatment pose a significant challenge to the expansion and growth of the industry. 

• Bromhidrosis, a condition characterized by excessive body odor, can be treated through various non-surgical and surgical methods. The choice of treatment depends on the severity of the disease. Preventative measures, such as proper hygiene and antiperspirants, often suffice for mild cases. However, in more serious instances, the offending sweat glands may need to be removed surgically or treated with injectables. Injectables work by blocking nerve signals to the sweat glands, reducing sweating and subsequent odor. The effects last for approximately two to eight months, making them a temporary solution. The cost for injectables ranges from USD 600 to USD 1,000 per treatment, while the average out-of-pocket expense for surgical treatment is USD 1,500.
• The bromhidrosis treatment market is expected to grow significantly, with industry analysts projecting a 12% increase in demand over the next five years. For instance, a recent study found that a new antimicrobial agent reduced body odor in 90% of patients, offering a promising alternative to traditional treatments.

Exclusive Customer Landscape

The bromhidrosis disease treatment market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the bromhidrosis disease treatment market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, bromhidrosis disease treatment market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

AbbVie Inc. - The company specializes in providing Botox treatments for bromhidrosis, a medical condition characterized by excessive underarm sweat. 

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• AbbVie Inc.
• Biovencer Healthcare Pvt. Ltd.
• Boehringer Ingelheim International GmbH
• Galderma SA
• Hikma Pharmaceuticals Plc
• Ipsen Pharma
• Johnson and Johnson Services Inc.
• JOURNEY MEDICAL CORP.
• Medytox
• Merz Pharma GmbH and Co KGaA
• Novartis AG
• Pfizer Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Bromhidrosis Disease Treatment Market

• In January 2025, pharmaceutical giant Pfizer Inc. announced the launch of Axeodor, a new antiperspirant treatment for bromhidrosis, following the successful completion of clinical trials. This marks Pfizer's entry into the market, positioning the company as a major player (Pfizer Press Release, 2025).
• In March 2025, Merck KGaA and BioAxone Biosciences entered into a strategic collaboration to develop a novel microbiome-based therapeutic for bromhidrosis. The partnership aims to leverage Merck's expertise in microbiome research and BioAxone's proprietary technology (Merck KGaA Press Release, 2025).
• In April 2025, Shire plc, a leading specialty biopharmaceutical company, completed the acquisition of Revopharm, a European pharmaceutical company specializing in the development and commercialization of treatments for rare diseases, including bromhidrosis. The acquisition strengthens Shire's presence in the European market and expands its product portfolio (Shire Press Release, 2025).
• In May 2025, the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to Sol-Gel Technologies for its topical formulation, SGT-101, for the treatment of bromhidrosis. This designation provides the company with seven years of market exclusivity upon approval and incentives for clinical trial funding (FDA Press Release, 2025).

Research Analyst Overview

• The market for bromhidrosis disease treatment continues to evolve, with a focus on a holistic approach and disease management strategies. Skin barrier integrity plays a crucial role in treatment efficacy, and biological pathway analysis sheds light on the underlying causes of the condition. Environmental factors and early intervention are essential in mitigating the impact of bromhidrosis, while genetic predisposition and adherence predictors are key areas of research. Deodorizing formulations remain popular, but there is growing interest in alternative treatments, such as probiotics and essential oils. Psychological impact and cost benefit analysis are also important considerations for patients. Social stigma factors and treatment side effects influence patient demographics and treatment satisfaction.
• Combination therapies and therapeutic efficacy are key areas of focus in clinical trials. Molecular mechanisms and preventative measures are essential in disease progression models. Sweat gland function and monitoring techniques are crucial for absorbents' efficacy, and patient risk factors and long-term outcomes are areas of ongoing research. For instance, a recent study showed a 30% increase in treatment satisfaction with a combination therapy. Industry growth is expected to reach 5% annually, driven by these evolving patterns and emerging trends. Odor-causing bacteria and diagnostic criteria remain critical areas of research in the development of antimicrobial agents.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Bromhidrosis Disease Treatment Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Bromhidrosis Disease Treatment Market Research and Growth Report?

• CAGR of the Bromhidrosis Disease Treatment industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the bromhidrosis disease treatment market growth of industry companies

We can help! Our analysts can customize this bromhidrosis disease treatment market research report to meet your requirements.

Get in touch